Navigation Links
EntreMed in Medical Technology

Entremed Presents Results of ENMD-2076 Phase 1 Study in Advanced Cancer Patients

... antitumor activity in preclinical models. entremed Vice President and Chief Medical Officer, Carolyn ...e pathology of hematological cancers. About entremed EntreMed, Inc. is a clinical-stage pharmaceutic...heumatoid arthritis. Additional information about entremed is available on the Company's web site at www.en...

EntreMed Presents Initial Clinical Results for ENMD-2076

...based chemotherapy in breast cancer. In addition, entremed has received an Orphan Drug Designation from the F...g candidate, a No Objection Letter was received by entremed from Health Canada permitting ENMD-2076 to be used...ther expand the clinical development of ENMD-2076, entremed has received a No Objection Letter (NOL) from the ...

EntreMed Receives New Patent for 2-Methoxyestradiol Analogs

...s of 2- methoxyestradiol (2ME2). The patent grants entremed composition-of-matter and method of use intellectu...MDLOGO ) Analogs of 2ME2 have been developed by entremed to improve metabolic stability and retain or enhan...s owned exclusively by EntreMed. James S. Burns, entremed President & Chief Executive Officer, commented, "T...

EntreMed Presents MKC-1 Phase 2 Data at American Society of Clinical Oncology Annual Meeting

...taxel-resistant models. To date, MKC-1 has been evaluated in over 400 patients in multiple Phase 1 and 2 clinical trials. Carolyn F. Sidor, MD, MBA, entremed Vice President and Chief Medical Officer commented on the results, "Although we did not meet our overall goal for this study, we are encouraged by the...

EntreMed to Highlight ENMD-2076 Kinase Inhibitor at 2008 AACR Annual Meeting

...n/prnh/20010620/ENMDLOGO ) Mark R. Bray, Ph.D., entremed Vice President, Research, will give an oral presen...the special session, "New Drugs on the Horizon 2." entremed will share the podium with representatives from le...ies without cardiovascular effects. In addition, entremed scientists are scheduled for the following poster ...

EntreMed Achieves a Key Milestone Through Initiation of ENMD-2076 Clinical Program

...ogical cancers later this year." James S. Burns, entremed President & Chief Executive Officer commented, "EN... Phase 1 study will trigger a milestone payment by entremed pursuant to EntreMed's acquisition of Miikana Ther... Miikana stockholders, either in cash or shares of entremed common stock. About EntreMed EntreMed, Inc. is...

EntreMed Commences Continuous Dosing Clinical Trial For MKC-1

...effect with novel molecular imaging techniques," commented Dr. Glenn Liu. entremed Vice President and Chief Medical Officer, Carolyn F. Sidor, M.D., M.B.A., c... other diseases, such as rheumatoid arthritis. Additional information about entremed is available on the Company's web site at http://www.entremed.com and in ...

EntreMed to Present at The New York Society of Security Analysts Industry Conference

...egulation and inflammation - processes vital to the treatment of cancer and other diseases, such as rheumatoid arthritis. Additional information about entremed is available on the Company's web site at http://www.entremed.com and in various filings with the Securities and Exchange Commission. CONTACT: ...

EntreMed Commences Phase 2 Study with MKC-1 in Pancreatic Cancer

... of the cell cycle, and induce apoptosis. Carolyn F. Sidor, M.D., M.B.A., entremed Vice President and Chief Medical Officer, commented on the study, "Pancreat... other diseases, such as rheumatoid arthritis. Additional information about entremed is available on the Company's web site at http://www.entremed.com and in ...

EntreMed Shows Increased Survival With MKC-1 in Preclinical Renal Cell Cancer Model

...survival in cancer patients. Mark R. Bray, Ph.D., entremed Vice President, Research, commented on the results...ot a registered trademark of EntreMed, Inc. About entremed EntreMed, Inc. is a clinical-stage pharmaceutical...rheumatoid arthritis. Additional information about entremed is available on the Company's web site at http://...

EntreMed Reports Phase 1 PK and Preclinical Efficacy Results for ENMD-1198

...s overall antitumor effects. Mark R. Bray, Ph.D., entremed Vice President, Research, commented on the results...ny's web site at http://www.entremed.com . About entremed EntreMed, Inc. is a clinical-stage pharmaceutical...rheumatoid arthritis. Additional information about entremed is available on the Company's web site at http://...

EntreMed Raises $20 Million to Support Clinical Development Program

...less fees, was funded at closing. James S. Burns, entremed President and Chief Executive Officer, commented on the financing, "This transaction provides entremed with a non-dilutive financing vehicle that strengt...Aurora-angiogenesis inhibitor in oncology." About entremed EntreMed, Inc. is a clinical-stage pharmaceutical...

EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer

...ic breast cancer (MBC). The data were presented by entremed collaborators during the 2007 Breast Cancer Sympos...ny's web site at http://www.entremed.com . About entremed EntreMed, Inc. is a clinical-stage pharmaceutical...rheumatoid arthritis. Additional information about entremed is available on the Company's web site at http://...

EntreMed Presents Mechanism Data for Its Three Lead Oncology Compounds

...rapeutic agents. Carolyn F. Sidor, M.D., M.B.A., entremed Vice President and Chief Medical Officer, commente...w.entremed.com/">http://www.entremed.com . About entremed EntreMed, Inc. is a clinical-stage pharmaceutica...rheumatoid arthritis. Additional information about entremed is available on the Company's website at

EntreMed Presents Multi-Mechanism Antitumor Data for ENMD-1420 in Preclinical Models

...in inhibitor compounds. The data were presented by entremed scientists at the American Association for Cancer ... identification. Carolyn F. Sidor, M.D., M.B.A., entremed Vice President and Chief Medical Officer, stated, ...quence, leading to cell death (apoptosis). About entremed EntreMed, Inc. is a clinical-stage pharmaceutica...

EntreMed Presents Multi-Mechanism Results for ENMD-1198 at AACR Annual Meeting

...t candidate, ENMD-1198. The data were presented by entremed scientists and collaborators during two separate s...w.entremed.com/">http://www.entremed.com . About entremed EntreMed, Inc. is a clinical-stage pharmaceutica...rheumatoid arthritis. Additional information about entremed is available on the Company's website at

EntreMed Presents Preclinical Data for MKC-1 in Hematological Cancers

...target="_blank" href= "http://www.entremed.com/">www.entremed.com . About entremed EntreMed, Inc. is a clinical-stage pharmaceutical company developing ther... other diseases, such as rheumatoid arthritis. Additional information about entremed is available on the Company's website at http://www.entremed.com . About entremed EntreMed, Inc. is a clinical-stage pharmaceutical company developing ther... other diseases, such as rheumatoid arthritis. Additional information about entremed is available on the Company's web site at entremed Vice President and Chief Medical Officer, commente...s a registered trademark of EntreMed, Inc. About entremed EntreMed, Inc. is a clinical-stage pharmaceutica...rheumatoid arthritis. Additional information about entremed is available on the Company's web site at

Clinical Results From EntreMed's Panzem NCD and Taxol Breast Cancer Study Presented at ASCO

...anisms of action. Carolyn F. Sidor, M.D., M.B.A, entremed Vice President and Chief Medical Officer, commente...enefit from treatment with Panzem(R) NCD." About entremed EntreMed, Inc. is a clinical-stage pharmaceutica...rheumatoid arthritis. Additional information about entremed is available on the Company's website at
Other Tags
(Date:10/15/2014)... a non-traditional biophysics textbook and it describes how life ... of discovery into biological systems and provides an understanding ... is about how our genes make proteins that control ... cells in an organism. It quantifies the principles of ... be found on both large and small scales. The ...
(Date:10/15/2014)... , Oct. 15, 2014 NXT-ID, Inc. (NASDAQ: ... authentication company focused on the growing mobile commerce market releases photos ... in Times Square on Monday October 13 th . ... David Tunnel and angel investor Mr. Chad A. ... , CEO of NXT-ID thanked his investors and employees "for their ...
(Date:10/14/2014)... new study published in Cancer Research shows ... and colon cancers—can promote the development of skin cancers ... and survival of sun-damaged skin cells. , Previously considered ... proteins called sirtuins that help regulate genomic stability and ... SIRT6 helps repair DNA damage, which can lead to ...
Breaking Biology News(10 mins):New book about life as seen from physics 2Photo Release: NXT-ID Inc. Rings Opening Bell of the NASDAQ Stock Market October 13th 2Photo Release: NXT-ID Inc. Rings Opening Bell of the NASDAQ Stock Market October 13th 3Two-faced gene: SIRT6 prevents some cancers but promotes sun-induced skin cancer 2
(Date:10/25/2014)... New York, New York (PRWEB) October 25, 2014 ... of transvaginal mesh lawsuits ( http://www.vaginalmeshlawsuit2015.com/ ) ... multidistrict litigation underway in U.S. District Court, Southern ... Motion for Summary Judgment on Punitive Damages in ... Florida plaintiffs. In a ruling issued on October ...
(Date:10/25/2014)... 25, 2014 Limbkeepers® announced today that ... Innovations with Ed Begley Jr, airing 1st QTR 2015 ... In this episode, Innovations will focus on Limbkeepers® non ... fragile, thinning skin on arms, hands, and legs from ... these versatile products, which help reduce injuries, allow for ...
(Date:10/25/2014)... Steven Reinberg HealthDay ... The virus that causes common cold sores -- herpes simplex ... by Swedish researchers suggest. In fact, being a carrier ... of Alzheimer,s disease, the researchers found. "The identification ... dementia disorder is a breakthrough," said lead researcher Dr. Hugo ...
(Date:10/25/2014)... FRIDAY, Oct. 24, 2014 (HealthDay News) -- Researchers ... say their findings are cause for concern. ... that are raised for human consumption contribute to ... health, according to background information from the study. ... germs sicken about 2 million people and kill ...
(Date:10/25/2014)... News) -- Current osteoporosis screening guidelines and tools ... risk for osteoporosis-related fractures, a new study says. ... need tools that help us accurately predict who ... can target these at-risk people for preventive measures," ... in the division of general internal medicine and ...
Breaking Medicine News(10 mins):Health News:Transvaginal Mesh Lawsuits Move Forward, As Federal Judge Denies Motion for Summary Judgment on Punitive Damages in Florida Cases, Bernstein Liebhard LLP Reports 2Health News:Transvaginal Mesh Lawsuits Move Forward, As Federal Judge Denies Motion for Summary Judgment on Punitive Damages in Florida Cases, Bernstein Liebhard LLP Reports 3Health News:Transvaginal Mesh Lawsuits Move Forward, As Federal Judge Denies Motion for Summary Judgment on Punitive Damages in Florida Cases, Bernstein Liebhard LLP Reports 4Health News:Upcoming Episode of Innovations with Ed Begley, Jr. to Feature Limbkeepers® 2Health News:Studies Link Cold Sore Virus to Alzheimer's Risk 2Health News:Studies Link Cold Sore Virus to Alzheimer's Risk 3Health News:Researchers Say Antibiotics in Fish a Health Concern 2Health News:Osteoporosis Screening Guidelines May Miss Younger Women at Risk 2
Other Contents